Financial stress shouldn’t be part of a pancreatic cancer diagnosis.
Our Patient Financial Support Grants™ provide support to eligible patients facing financial challenges during diagnosis and treatment.
Learn more at https://t.co/FdJRaRO5dM💜
#PancreaticCancer#ChangetheOutcome
🎉 Congrats to Jake Barralet of The Institute's Surgical and Interventional Sciences program on receiving $1.65M from @NSERC_CRSNG's CREATE program!🔬
🔗https://t.co/PBGmTtBbTR
Danielle Martin est une médecin de famille expérimentée et leader dans le domaine des soins de santé qui a des racines profondes dans University—Rosedale.
Nous sommes ravis de l’accueillir comme candidate libérale à la prochaine élection partielle.
AHPBA honors the life and legacy of Dr. Sean P. Cleary - leader, mentor, colleague, friend. Dr. Cleary changed AHPBA, and all who knew him, for the better. Read tribute: https://t.co/tYU5imNmC2
We are deeply saddened by the sudden passing of Dr. Sean Cleary.
CAGS past president and tireless advocate for general surgery, his leadership, mentorship, and friendship touched many.
We extend our heartfelt condolences to family and all who had the privilege of knowing him.
It is with deep sadness that the we mourn the sudden loss of our co-founder, past-president, mentor, colleague and friend Dr. Sean Cleary. A gifted surgeon and passionate advocate for the HPB community, his impact and friendship touched us all.
Our hearts are with his family ���
From @graokane@LabNotta & colleagues in @NatureComms :
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
https://t.co/vTX5mO9098
Another study showing the association between basal subtype & major KRAS allelic imbalance.
Yoshi Majima (founder of @PanCAN Japan) has been a passionate advocate for patients & families for over two decades. He talked about his own experience with surveillance and early detection of #PancreaticCancer.
From the G7 Cancer Conference on Poor Prognosis Cancers (Paris).
@MikeChuongMD@letswinpc Chemo if fit. Palliative RT on occasion. Have only used ablative/high dose RT in cases with reasonable evidence for systemic control.
Yesterday was a remarkable day as we celebrated the 40th anniversary of the T-cell receptor discovery with an inspiring symposium featuring leading immunologists, hosted by @UHN@pmcancercentre and @UofT. A big thank you to all who joined us in celebrating this milestone!
Dr. Rosalie Sears, members of our new External Scientific Advisory Committee, presents a fascinating keynote at the #TFRI10SM.
Dr. Sears is an international expert in pancreatic cancer.
🍁 MAESTRO: A Pan-Canadian project to accelerate #precisionmedicine for #pancreaticcancer🍁
🩺 Sadly, #PancreaticCancer is one of the deadliest cancers
🩺 Today, patients have very few treatment options, and those that exist are often ineffective
Cancer is hard - I commend Princess Kate for her courage in sharing her personal #cancer story 🙏
📌2 in 5 Canadians will be diagnosed with #cancer
📌Be aware, get screened
📌Early-onset cancers 📈
Wishing #KateMiddleton a full recovery ❤️🩹
👇thanks to @CBCTheNational for invite to amplify #awareness 🇨🇦
@KensingtonRoyal@CAMO_ACOM@BCCancer @UBCDoM
🔗https://t.co/EE3rUHSh6R